BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 2272633)

  • 1. Impact of activated glucose counterregulation on insulin requirements in insulin-dependent diabetes mellitus.
    Bolli GB; Perriello G
    Horm Metab Res Suppl; 1990; 24():87-96. PubMed ID: 2272633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.
    Cryer PE; Gerich JE
    N Engl J Med; 1985 Jul; 313(4):232-41. PubMed ID: 2861565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia).
    Bolli GB; Gottesman IS; Campbell PJ; Haymond MW; Cryer PE; Gerich JE
    N Engl J Med; 1984 Nov; 311(19):1214-9. PubMed ID: 6387483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus.
    Holstein A; Hammer C; Plaschke A; Ptak M; Kuhn J; Diekmann J; Kleesiek K; Egberts EH
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):429-34. PubMed ID: 15372362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal blood glucose control in type I diabetes mellitus.
    Bolli GB; Perriello G; Fanelli CG; De Feo P
    Diabetes Care; 1993 Dec; 16 Suppl 3():71-89. PubMed ID: 8299480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
    Campbell PJ; Bolli GB; Cryer PE; Gerich JE
    N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.
    Cryer PE
    Diabetologia; 2002 Jul; 45(7):937-48. PubMed ID: 12136392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin-antagonistic effect of the counterregulatory hormones.
    Lager I
    J Intern Med Suppl; 1991; 735():41-7. PubMed ID: 2043222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.
    De Feo P; Bolli G; Perriello G; De Cosmo S; Compagnucci P; Angeletti G; Santeusanio F; Gerich JE; Motolese M; Brunetti P
    Diabetes; 1983 Oct; 32(10):887-93. PubMed ID: 6311652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state.
    Fanelli CG; Pampanelli S; Porcellati F; Bartocci L; Scionti L; Rossetti P; Bolli GB
    Diabetologia; 2003 Jan; 46(1):53-64. PubMed ID: 12637983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of continuous glucose monitoring system (CGMS) in monitoring glycaemic profile in small children with diabetes type 1].
    Głowińska-Olszewska B; Urban M; Peczyńska J; Florys B; Kowalewski M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):237-43. PubMed ID: 16232362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol intake impairs glucose counterregulation during acute insulin-induced hypoglycemia in IDDM patients. Evidence for a critical role of free fatty acids.
    Avogaro A; Beltramello P; Gnudi L; Maran A; Valerio A; Miola M; Marin N; Crepaldi C; Confortin L; Costa F
    Diabetes; 1993 Nov; 42(11):1626-34. PubMed ID: 8405705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dawn or Somogyi phenomenon? High morning fasting blood sugar values in young type-1 diabetics].
    Holl RW; Heinze E
    Dtsch Med Wochenschr; 1992 Oct; 117(40):1503-7. PubMed ID: 1396135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morning insulin requirements. Critique of dawn and meal phenomena.
    Blackard WG; Barlascini CO; Clore JN; Nestler JE
    Diabetes; 1989 Mar; 38(3):273-7. PubMed ID: 2645185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of glucose metabolism in man.
    Cryer PE
    J Intern Med Suppl; 1991; 735():31-9. PubMed ID: 1675054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counterregulatory hormones in insulin-treated diabetic patients admitted to an accident and emergency department with hypoglycaemia.
    Hvidberg A; Christensen NJ; Hilsted J
    Diabet Med; 1998 Mar; 15(3):199-204. PubMed ID: 9545120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.
    Kollind M
    Acta Med Scand Suppl; 1988; 727():1-56. PubMed ID: 2903616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycaemia and gastric emptying.
    Berne C
    Diabet Med; 1996 Sep; 13(9 Suppl 5):S28-30. PubMed ID: 8894467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.